Patent US4371514A successfully refreshed from Google Patents.
US4371514A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Radioimmunoassay of pterins and novel pterin derivatives useful therefor
Assignee: Fujifilm RI Pharma Co Ltd
•
Filing: 1980-07-07
•
Granted: 1983-02-01
•
Expires: 2000-07-07
Abstract
Abstract Pterin derivatives are described having the formula (I) ##STR1## wherein R represents a hydroxyphenyl group, a radioiodinated hydroxyphenyl group, a tyraminocarbonyl group, a radioiodinated tyraminocarbonyl group, a proteinocarbonyl group or a carboxy group; Q represents a straight or branched chain alkylene group having 1 to 6 carbon atoms; and R 6 and R 7 each represents a hydrogen, an alkyl group having from 1 to 6 carbon atoms, a hydroxyalkyl group having from 1 to 6 carbon atoms; and a radioimmunoassay method is described using a radioiodinated 4-hydroxy-2-tyraminopteridine derivative or a radioiodinated 4-hydroxy-2-tyraminocarbonylalkylaminopteridine derivative as the tracer.
Inventors
- 👤 Toshiharu Nagatsu
- 👤 Takeshi Kato
- 👤 Tokio Yamaguchi
- 👤 Miki Akino
- 👤 Sadao Matsuura
- 👤 Takashi Sugimoto
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 19:48
CPC Classifications
C; C07; C07D; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/46; C07D239/48; C07D475/00; C07D475/02; C07D475/04; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/534; G01N33/82
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
71 words
A compound of the formula ##STR8## wherein R represents a hydroxyphenyl, a radioiodinated hydroxyphenyl, a tyraminocarbonyl, a radioiodinated tyraminocarbonyl, a proteinocarbonyl group or a carboxyl; Q represents a straight or branched chain alkylene group having from 1 to 6 carbon atoms; and R 6 and R 7 each represents hydrogen, and alkyl group having from 1 to 6 carbon atoms, or a hydroxyalkyl group having from 1 to 6 carbon atoms.
Claim 2
Dependent Claim
71 words
A compound of the formula ##STR8## wherein R represents a hydroxyphenyl, a radioiodinated hydroxyphenyl, a tyraminocarbonyl, a radioiodinated tyraminocarbonyl, a proteinocarbonyl group or a carboxyl; Q represents a straight or branched chain alkylene group having from 1 to 6 carbon atoms; and R 6 and R 7 each represents hydrogen, and alkyl group having from 1 to 6 carbon atoms, or a hydroxyalkyl group having from 1 to 6 carbon atoms.
Claim 3
Dependent Claim
12 words
A compound as in claim 1, wherein the compound is radioiodinated 4-hydroxy-2-[2-(4-hydroxyphenyl)ethylamino]-6-(L-erythro-1,2-dihydroxypropyl)pteridine.
Claim 4
Dependent Claim
12 words
A compound as in claim 1, wherein the compound is radioiodinated 2-[5-(tyraminocarbonyl)pentylamino]-4-hydroxy-6-(L-erythro-1,2-dihydroxypropyl)pteridine.
Claim 5
Dependent Claim
12 words
A compound as in claim 1, wherein the compound is 2-(5-carboxypentylamino)-4-hydroxy-6-(L-erythro-1,2-dihydroxypropyl)pteridine-BSA conjugate.
Claim 6
Dependent Claim
11 words
A compound as in claim 1, wherein the compound is 2-(5-carboxypentylamino)-4-hydroxy-6-(L-erythro-1,2-dihydroxypropyl)pteridine.
Claim 7
Dependent Claim
12 words
A compound as in claim 1, wherein the compound is radioiodinated 4-hydroxy-2-[2-(4-hydroxyphenyl)ethylamino]-6-(L-erythro-1,2,3-trihydroxypropyl)pteridine.
Claim 8
Dependent Claim
12 words
A compound as in claim 1, wherein the compound is radioiodinated 2-[5-(tyraminocarbonyl)pentylamino]-4-hydroxy-6-(L-erythro-1,2,3-trihydroxypropyl)pteridine.
Claim 9
Dependent Claim
12 words
A compound as in claim 1, wherein the compound is 2-(5-carboxypentylamino)-4-hydroxy-6-(L-erythro-1,2,3-trihydroxypropyl)-pteridine-BSA conjugate.
Claim 10
Dependent Claim
11 words
A compound as in claim 1, wherein the compound is 2-(5-carboxypentylamino)-4-hydroxy-6-(L-erythro-1,2,3-trihydroxypropyl)pteridine.
Claim 11
Independent Claim
117 words
A method of radioimmunoassay for determining pterines, comprising mixing an unknown sample or a known amount of a standard with a labeled compound of the formula ##STR9## wherein R represents a radioiodinated hydroxyphenyl group or a radioiodinated tyraminocarbonyl group; Q represents a straight or branched chain alkylene group having from 1 to 6 carbon atoms; and R 6 and R 7 each represents hydrogen, an alkyl group having from 1 to 6 carbon atoms, or a hydroxyalkyl group having from 1 to 6 carbon atoms, and anti-pterines antibody, separating bound labeled compound from remaining free labeled compound, and counting the radiation emitted from either the bound labeled compound or the free labeled compound in a gamma counter.
Claim 12
Independent Claim
117 words
A method of radioimmunoassay for determining pterines, comprising mixing an unknown sample or a known amount of a standard with a labeled compound of the formula ##STR9## wherein R represents a radioiodinated hydroxyphenyl group or a radioiodinated tyraminocarbonyl group; Q represents a straight or branched chain alkylene group having from 1 to 6 carbon atoms; and R 6 and R 7 each represents hydrogen, an alkyl group having from 1 to 6 carbon atoms, or a hydroxyalkyl group having from 1 to 6 carbon atoms, and anti-pterines antibody, separating bound labeled compound from remaining free labeled compound, and counting the radiation emitted from either the bound labeled compound or the free labeled compound in a gamma counter.
Claim 13
Dependent Claim
24 words
A method of radioimmunoassay for determining pterins as in claim 10 wherein the anti-pterines antibody is prepared by using 2-(5-carboxypentylamino)-4-hydroxy-6-(L-erythro-1,2-dihydroxypropyl)pteridine-BSA conjugate as an antigen.
Claim 14
Dependent Claim
18 words
A method of radioimmunoassay for determining pterines as in claim 10 wherein the labeled compound is radioiodinated 4-hydroxy-2-[2-(4-hydroxyphenyl)ethylamino]-6-(L-erythro-1,2-dihydroxypropyl)pteridine.
Claim 15
Dependent Claim
18 words
A method of radioimmunoassay for determining pterins as in claim 10 wherein the labeled compound is radioiodinated 2-[5-(tryaminocarbonyl)pentylamino]-4-hydroxy-6-(L-erythro-1,2-dihydroxypropyl)pteridine.
Claim 16
Dependent Claim
24 words
A method of radioimmunoassay for determining pterines as in claim 10 wherein the anti-pterines antibody is prepared by using 2-(5-carboxypentylamino)-4-hydroxy-6-(L-erythro-1,2,3-trihydroxylpropyl)pteridine-BSA conjugate as an antigen.
Claim 17
Dependent Claim
18 words
A method of radioimmunoassay for determining pterines as in claim 10 wherein the labeled compound is radioiodinated 2-[5-(tyraminocarbonyl)pentylamino]-4-hydroxy-6-(L-erythro-1,2,3-trihydroxypropyl)pteridine.
Claim 18
Dependent Claim
18 words
A method of radioimmunoassay for determining pterines as in claim 10 wherein the labeled compound is radioiodinated 4-hydroxy-2-[2-(4-hydroxyphenyl)ethylamino]-6-(L-erythro-1,2,3-trihydroxypropyl)pteridine.
References Cited (Backward Citations)
GB785353A
Cited
GB785352A
Cited
US4202976A
Cited
US4115065A
Cited
US3972991A
Cited
US3989812A
Cited
US4091087A
Cited
US3988431A
Cited
US4028465A
Cited
DE2741677A1
Cited
US4276280A
Cited
US4146602A
Cited
US4136159A
Cited
US4135880A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-01-31 | 1986-08-02 | 1987-02-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-01-31 | 1990-08-02 | 1991-02-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-01-31 | 1994-08-02 | 1995-02-01 | $7700.00 | Window Closed / Lapsed |